Kactus Biosystems
Shanghai
About Kactus Biosystems
Kactus Biosystems is a biotechnology company that designs and manufactures high-quality and bioactive recombinant proteins. The company is committed to improving cutting-edge therapeutic technologies such as cell therapies, gene editing, immunotechnology, and vaccines. They test the configurations of your protein/enzyme in various expression systems after creating 3D models of it to optimize protein folding, maximize bioactivity, and improve stability. Their focus is on customization and tailored solutions, so your potential for innovation is limitless.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $30.7M
- Funding stage: Early Stage Venture
- Last round: Series B (Oct 2022)
- Website: kactusbio.com
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/kactus-biosystems-90935 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.